ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1831

Role of Long Non-Coding RNA H19 in Mediating Skin Fibrosis in Systemic Sclerosis

Begoña Caballero-Ruiz1, Christopher Wasson2, Rebecca Ross3 and Francesco Del Galdo2, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2University of Leeds, Leeds, United Kingdom, 3Medicine and Health, University of Leeds, Leeds, United Kingdom

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Fibroblasts, Dermal, interferon, Scleroderma, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic Sclerosis (SSc) is an immune driven condition leading to skin fibrosis, as well as internal organs. Dermal fibroblasts are the key cellular elements of skin fibrosis, which cause the accumulation of extracellular matrix (ECM) proteins, altering tissue architecture and function. The triggers responsible for re-establishing tissue homeostasis and functional skin following inflammation vs. scarring and loss of function are not known.Recently we have shown that dermal fibroblast can induce a Type I IFN response in keratinocytes, partially through their secreted exosomes.
RNAseqanalysis revealed that lncRNA H19 is the most significantly increased gene in SSc fibroblast exosomes compared to Healthy fibroblast derived-exosomes. Here we aimed to understand the role of lncRNA H19 mediating the fibrotic signature and skin homeostasis in SSc skin.
 

Methods: Skin biopsies were obtained from the forearms of adult patients with diffuse SSc or healthy controls. Fibroblasts were isolated and immortalized using human telomerase reverse transcriptase (hTERT). In situ Hybridization was performed to detect H19 levels in skin from SSc and co-immunohistochemistry for COL1A1. H19 was overexpressed by retroviral transduction and knockdown using siRNA. RT-qPCR assay was used to measure transcript levels of H19 and profibrotic markers. Gel contraction assays used to analyse myofibroblast activity in vitro. Co-culture of fibroblasts and Hacats was performed by Transwell assays. Phosphorylation and total expression of STAT3 and STAT1 protein and profibrotic markers was assessed by immunoblotting.  

 

Results: RNAscope assay demonstrated higher H19 levels in SSc skin compared to Healthy, with detectable signal spread across dermal fibroblast, keratinocytes, endothelial cells and fat tissue in the skin. H19 lncRNA expression was highly variable across SSc explanted fibroblasts, and strongly correlated with mRNA levels of Col1A1 (p=0.007), SMA (p=0.049) and CTGF/CNN2 (p=0.022). 
Knockdown of H19 in SSc fibroblasts had a 0.75 fold decrease in CTGF/CNN2 (p= 0.023) and 0.6 in COL1A1 (p= 0.019) gene expression relative to SCR SSc fibroblast. Accordingly, H19 knockdown significantly reduced the ability of SSc fibroblasts to contract collagen matrix (p=0.038). On the contrary, overexpression of H19 in healthy fibroblasts significantly increased pSMAD3, pSTAT3 and CTGF/CNN2 protein levels.  Importantly, in keratinocytes/fibroblast co-culture models, knockdown of H19 in SSc fibroblast prevented keratinocytes activation as assessed by total and phosphorylation protein levels of STAT3 and STAT1. 
 

Conclusion: All together we show that H19 lncRNA is upregulated in skin from SSc patients and  SSc primary dermal fibroblast comparing to Healthy. Our studies indicate that H19 contributes to the profibrotic activation of dermal fibroblasts and the proinflammatory activation of keratinocytes through STAT3 dependent signalling. 
 


Disclosures: B. Caballero-Ruiz: None; C. Wasson: None; R. Ross: Deepcure, 5; F. Del Galdo: AbbVie, 2, 5, Argenx, 2, Arxx, 2, 5, AstraZeneca, 2, 5, Boehringer Ingelheim, 2, 5, Chemomab, 5, Deepcure, 2, GlaxoSmithKline (GSK), 2, Janssen, 2, Mitsubishi Tanabe, 5, Novartis, 2, Ventus, 2.

To cite this abstract in AMA style:

Caballero-Ruiz B, Wasson C, Ross R, Del Galdo F. Role of Long Non-Coding RNA H19 in Mediating Skin Fibrosis in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/role-of-long-non-coding-rna-h19-in-mediating-skin-fibrosis-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-long-non-coding-rna-h19-in-mediating-skin-fibrosis-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology